30th April 2024
The findings could help more patients to benefit from the latest advances in immunotherapies.
Read more21st March 2024
Congratulations to Dr Luigi Ombrato who has been awarded a £700k grant to investigate the earliest stages of cancer spread.
Read more28th July 2023
The findings could help us to distinguish who will benefit from treatment
Read more19th August 2022
This summer, the Breast Cancer Now Tissue Bank is celebrating 10 years of enabling vital breast cancer research. Since opening in 2012, the Tissue Bank has provided researchers across the globe with access to high-quality breast tissue, breast cells and blood samples from breast cancer patients, driving advances in breast cancer diagnosis and treatment.
Read more10th February 2022
An immunotherapy drug called ‘pembrolizumab’ has been shown to significantly reduce disease recurrence in patients with the most aggressive type of breast cancer, according to results from a phase III clinical trial led by Professor Peter Schmid from Queen Mary University of London and Barts Health NHS Trust.
Read more28th October 2021
In recognition of Breast Cancer Awareness Month, we spoke with Dr Ioanna Keklikoglou, Lecturer and Group Leader in the Centre for Tumour Microenvironment at Barts Cancer Institute, Queen Mary University of London. Dr Keklikoglou’s research focuses on understanding the molecular and cellular mechanisms that control resistance to anti-cancer therapies in breast cancer.
Read more